OTLK - .9104 Pre-market now at 1.28/1.29 Oppenheimer Initiates Coverage On Outlook Therapeutics, Inc. - Common Stock with Outperform Rating, Announces $12 Price Target https://www.tradescores.com/StockReport/otlk